Marco Atteritano

Summary

Affiliation: University of Messina
Country: Italy

Publications

  1. ncbi request reprint Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    J Clin Endocrinol Metab 92:3068-75. 2007
  2. doi request reprint Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    Eur J Pharmacol 589:22-6. 2008
  3. ncbi request reprint The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, AOU Policlinico G Martino, Via C Valeria, Messina, Italy
    Gene 508:206-10. 2012
  4. ncbi request reprint Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, Section of Physiology and Human Nutrition, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 93:4787-96. 2008
  5. ncbi request reprint Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial
    Alessandra Bitto
    Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 95:3067-72. 2010
  6. ncbi request reprint Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial
    Herbert Marini
    Azienda Ospedaliera Universitaria Policlinico G Martino, University of Messina, Messina, Italy
    Ann Intern Med 146:839-47. 2007
  7. ncbi request reprint Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study
    Maria Letizia Cannata
    Department of Obstetrical and Gynaecological Sciences, University of Messina, Messina, Italy
    Menopause 14:648-55. 2007
  8. doi request reprint Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Policlinico G Martino, Via C Valeria 1, 98123, Messina, Italy
    Intern Emerg Med 8:485-91. 2013
  9. doi request reprint The ESR2 AluI gene polymorphism is associated with bone mineral density in postmenopausal women
    Monica Currò
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, Via C Valeria, Policlinico G Martino, 98124 Messina, Italy
    J Steroid Biochem Mol Biol 127:413-7. 2011
  10. ncbi request reprint Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer
    Nancy Morabito
    Department of Internal Medicine, University of Messina, Messina, Italy
    J Bone Miner Res 19:1766-70. 2004

Collaborators

  • Alessandra Bitto
  • Rosario D'Anna
  • Giorgio Basile
  • Michele Buemi
  • Anna Meo
  • Onofrio Triolo
  • Vincenzo Adamo
  • Antonino Santangelo
  • Andrea Guala
  • Herbert Marini
  • Francesca Polito
  • Domenica Altavilla
  • Francesco Squadrito
  • Nicola Frisina
  • Maria Letizia Cannata
  • Agostino Gaudio
  • Francesco Corrado
  • Letteria Minutoli
  • Monica Currò
  • Antonino Catalano
  • Francesco Cancellieri
  • Elena Bianca Adamo
  • Susanna Mazzaferro
  • Alessia Frisina
  • Carla Lubrano
  • Antonino Lasco
  • Nancy Morabito
  • Riccardo Ientile
  • Daniela Caccamo
  • Elena B Adamo
  • Nadia Ferlazzo
  • Angela Alibrandi
  • Rolando Marini
  • Michele Bonaiuto
  • Steven Wilson
  • Nunziata Morabito
  • Domenico Cucinotta
  • Salvatore Condello
  • Robert M Levy
  • Vincenzo Di Stefano
  • Marianna Faraci
  • Bruce P Burnett
  • Carlo Sansotta
  • Giovanni Baviera
  • Francesco Antico
  • Aldo Trifiletti
  • Darwin Melloni
  • Maria Antonia Pizzoleo
  • Roberta Guarino
  • Maria Cincotta
  • Mariangela La Rosa
  • Giuseppina Anastasi

Detail Information

Publications14

  1. ncbi request reprint Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    J Clin Endocrinol Metab 92:3068-75. 2007
    ..Genistein, a soy isoflavone, has received wide attention over the last few years because of its potential preventive role for cardiovascular disease...
  2. doi request reprint Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    Eur J Pharmacol 589:22-6. 2008
    ..The protective effect on genomic damage appears to be a particularly promising tool in reducing the risk of cancer...
  3. ncbi request reprint The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, AOU Policlinico G Martino, Via C Valeria, Messina, Italy
    Gene 508:206-10. 2012
    ..The present data strongly indicate that genotyping for the ESR2 AluI 1730G>A gene variant should be included in a screening panel for assessment of cardiovascular risk in menopausal women...
  4. ncbi request reprint Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, Section of Physiology and Human Nutrition, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 93:4787-96. 2008
    ..Genistein aglycone improves bone metabolism in women. However, questions about the long-term safety of genistein on breast as well as its continued efficacy still remain...
  5. ncbi request reprint Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial
    Alessandra Bitto
    Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 95:3067-72. 2010
    ..Genistein aglycone positively affects postmenopausal symptoms. However, questions about its long-term safety on the thyroid gland still remain...
  6. ncbi request reprint Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial
    Herbert Marini
    Azienda Ospedaliera Universitaria Policlinico G Martino, University of Messina, Messina, Italy
    Ann Intern Med 146:839-47. 2007
    ..Observational studies and small trials of short duration suggest that the isoflavone phytoestrogen genistein reduces bone loss, but the evidence is not definitive...
  7. ncbi request reprint Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study
    Maria Letizia Cannata
    Department of Obstetrical and Gynaecological Sciences, University of Messina, Messina, Italy
    Menopause 14:648-55. 2007
    ....
  8. doi request reprint Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Policlinico G Martino, Via C Valeria 1, 98123, Messina, Italy
    Intern Emerg Med 8:485-91. 2013
    ..Postmenopausal women with depressive disorder have an elevated risk for osteoporosis. Our data suggest that a high level of parathyroid hormone may play a role in the pathogenetic process underlying osteopenia in these patients...
  9. doi request reprint The ESR2 AluI gene polymorphism is associated with bone mineral density in postmenopausal women
    Monica Currò
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, Via C Valeria, Policlinico G Martino, 98124 Messina, Italy
    J Steroid Biochem Mol Biol 127:413-7. 2011
    ....
  10. ncbi request reprint Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer
    Nancy Morabito
    Department of Internal Medicine, University of Messina, Messina, Italy
    J Bone Miner Res 19:1766-70. 2004
    ..Neridronate, a relatively new bisphosphonate, is able to prevent bone loss in patients with prostate cancer during androgen ablation...
  11. pmc Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Messina, Italy
    PLoS ONE 8:e66991. 2013
    ..The aim of our study was to elucidate the pathophysiology of systemic sclerosis-related osteoporosis and the prevalence of vertebral fragility fracture in postmenopausal women with systemic sclerosis (SSc)...
  12. doi request reprint Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis
    Antonino Catalano
    Department of Internal Medicine, University of Messina, Messina, Italy
    Calcif Tissue Int 90:279-85. 2012
    ..005 vs. placebo). Our data demonstrate that cholecalciferol at a dose of 300,000 IU reduces the intensity of musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis...
  13. ncbi request reprint Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle
    Nunziata Morabito
    Department of Internal Medicine, University of Messina, Messina, Italy
    J Bone Miner Res 19:722-7. 2004
    ..These data are extremely important for the possible therapeutic use of RANKL antagonists such as OPG in thalassemia-induced osteoporosis...
  14. doi request reprint OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, Section of Physiology and Human Nutrition, A O U Policlinico G Martino, Messina, Italy
    J Bone Miner Res 23:715-20. 2008
    ..Genistein, an isoflavone representing 1-5% of total phytoestrogen content in soybean products, may positively regulate cellular bone metabolism, but its mechanism of action on bone is not yet fully understood...